Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

Clinical trial NCT00006269 · TERMINATED

Trial details

NCT number: NCT00006269
Sponsor: Novartis
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer Diarrhea

Start date: 1999-12-01
Primary completion: 1999-12-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.